Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells

被引:55
|
作者
Wen, R
Cole, GA
Surman, S
Blackman, MA
Woodland, DL
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT IMMUNOL, MEMPHIS, TN 38105 USA
[2] UNIV TENNESSEE, DEPT PATHOL, MEMPHIS, TN 38163 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 183卷 / 03期
关键词
D O I
10.1084/jem.183.3.1083
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies have shown that only a subset of major histocompatibility complex (MHC) class II molecules are able to present bacterial superantigens to T cells, leading to the suggestion that class II-associated peptides may influence superantigen presentation. Here, we have assessed the potential role of peptides on superantigen presentation by (a) analyzing the ability of superantigens to block peptide-specific T cell responses and (b) analyzing the ability of individual peptides to promote superantigen presentation on I-A(b)-expressing T2 cells that have a quantitative defect in antigen processing. A series of peptides is described that specifically promote either toxic shock syndrome toxin (TSST) 1 or staphylococcal enterotoxin A (SEA) presentation. Whereas some peptides promoted the presentation of TSST-1 (almost 5,000-fold in the case of one peptide), other peptides promoted the presentation of SEA. These data demonstrate that MHC class II-associated peptides differentially influence the presentation of bacterial superantigens to T cells.
引用
收藏
页码:1083 / 1092
页数:10
相关论文
共 50 条
  • [1] Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells
    Wen, R
    Broussard, DR
    Surman, S
    Hogg, TL
    Blackman, MA
    Woodland, DL
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (03) : 772 - 781
  • [2] A biological function for the XP motif within the N terminus of major histocompatibility complex class II-associated peptides
    Breloer, M
    Ehrlich, S
    Fleischer, B
    vonBonin, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) : 1825 - 1829
  • [3] A secreted form of the major histocompatibility complex class II-associated invariant chain inhibiting T cell activation
    Eynon, EE
    Schlax, C
    Pieters, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) : 26266 - 26271
  • [4] Molecular docking of superantigens with class II major histocompatibility complex proteins
    Olson, MA
    Cuff, L
    JOURNAL OF MOLECULAR RECOGNITION, 1997, 10 (06) : 277 - 289
  • [5] EXOGENOUS PEPTIDES COMPETE FOR THE PRESENTATION OF ENDOGENOUS ANTIGENS TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-RESTRICTED T-CELLS
    ADORINI, L
    MORENO, J
    MOMBURG, F
    HAMMERLING, GJ
    GUERY, JC
    VALLI, A
    FUCHS, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (04): : 945 - 948
  • [6] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-ASSOCIATED PEPTIDES DETERMINE THE BINDING OF THE SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
    VONBONIN, A
    EHRLICH, S
    MALCHEREK, G
    FLEISCHER, B
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2894 - 2898
  • [7] DIRECT OBSERVATION OF DISORDERED REGIONS IN THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-ASSOCIATED INVARIANT CHAIN
    JASANOFF, A
    PARK, SJ
    WILEY, DC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) : 9900 - 9904
  • [8] Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO
    van Ham, M
    van Lith, M
    Lillemeier, B
    Tjin, E
    Grüneberg, U
    Rahman, D
    Pastoors, L
    van Meijgaarden, K
    Roucard, C
    Trowsdale, J
    Ottenhoff, T
    Pappin, D
    Neefjes, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07): : 1127 - 1135
  • [9] T-CELL RECEPTOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INTERACTION IS REQUIRED FOR THE T-CELL RESPONSE TO BACTERIAL SUPERANTIGENS
    LABRECQUE, N
    THIBODEAU, J
    MOURAD, W
    SEKALY, RP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (05): : 1921 - 1929
  • [10] DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms
    Rinderknecht, Cornelia H.
    Roh, Sujin
    Pashine, Achal
    Belmares, Michael P.
    Patil, Namrata S.
    Lu, Ning
    Truong, Phi
    Hou, Tieying
    Macaubas, Claudia
    Yoon, Taejin
    Wang, Nan
    Busch, Robert
    Mellins, Elizabeth D.
    IMMUNOLOGY, 2010, 131 (01) : 18 - 32